In the MWM test, AD mice exhibited a longer time to find the target quadrant and a lower frequency of platform crossings than WT mice (Figure 1B, both p < 0.001); however, AET treatment significantly improved cognitive deficits in APP/PS1 mice (Figure 1A,B, all p < 0.01). The gene discussed is APP; the disease is Cognitive impairment.